Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
Griffithsin (GRFT) is a broad-spectrum antiviral protein that is effective against several glycosylated viruses. Here, we have evaluated the in vitro and in vivo antiviral activities of GRFT against Japanese encephalitis virus (JEV) infection. In vitro experiments showed that treatment of JEV with GRFT before inoculation of BHK-21 cells inhibited infection in a dose-dependent manner, with 99 % inhibition at 100 μg/ml and a 50 % inhibitory concentration (IC50) of 265 ng/ml (20 nM). Binding assays suggested that binding of GRFT to JEV virions inhibited JEV infection. In vivo experiment showed that GRFT (5 mg/kg) administered intraperitoneally before virus infection could completely prevent mortality in mice challenged intraperitoneally with a lethal dose of JEV. Our study also suggested that GRFT prevents JEV infection at the entry phase by targeting the virus. Collectively, our data demonstrate that GRFT is an antiviral agent with potential application in the development of therapeutics against JEV or other flavivirus infections.
KeywordsAntiviral Activity Japanese Encephalitis Virus Plaque Assay Japanese Encephalitis Virus Japanese Encephalitis Virus Infection
This project was funded by the priority academic program development of Jiangsu Higher Education Institutions.
- 8.Chiu YH, Chan Y-L, Li T-L, Wu CJ (2011) Inhibition of Japanese encephalitis virus infection by the sulfated polysaccharides extracts from Ulva lactuca. Mar Biotechnol 12:1–11Google Scholar
- 9.Dutta K, Rangarajan PN, Vrati S, Basu A (2010) Japanese encephalitis: pathogenesis, prophylactics and therapeutics. Curr Sci 98:326Google Scholar
- 13.Kim JM, Yun SI, Song BH, Hahn YS, Lee CH, Oh HW, Lee YM (2008) A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. J Virol 82:7846PubMedCrossRefGoogle Scholar
- 14.Lindenbach BD, Thiel H-Ju, Rice CM (2007) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 1108–1109Google Scholar
- 16.Mori T, O’Keefe BR, Sowder RC 2nd, Bringans S, Gardella R, Berg S, Cochran P, Turpin JA, Buckheit RW Jr, McMahon JB, Boyd MR (2005) Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem 280:9345–9353PubMedCrossRefGoogle Scholar
- 18.O’Keefe BR, Giomarelli B, Barnard DL, Shenoy SR, Chan PKS, McMahon JB, Palmer KE, Barnett BW, Meyerholz DK, Wohlford-Lenane CL (2010) Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol 84:2511PubMedCrossRefGoogle Scholar
- 19.Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497Google Scholar